Vitamin Blue Stock Profit Margin
VTMB Stock | USD 0.0001 0.00 0.00% |
Vitamin Blue fundamentals help investors to digest information that contributes to Vitamin Blue's financial success or failures. It also enables traders to predict the movement of Vitamin Pink Sheet. The fundamental analysis module provides a way to measure Vitamin Blue's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vitamin Blue pink sheet.
Vitamin |
Vitamin Blue Company Profit Margin Analysis
Vitamin Blue's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition |
Based on the latest financial disclosure, Vitamin Blue has a Profit Margin of 0.0%. This is 100.0% lower than that of the Consumer Cyclical sector and 100.0% lower than that of the Leisure industry. The profit margin for all United States stocks is 100.0% lower than that of the firm.
Vitamin Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vitamin Blue's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Vitamin Blue could also be used in its relative valuation, which is a method of valuing Vitamin Blue by comparing valuation metrics of similar companies.Vitamin Blue is currently under evaluation in profit margin category among related companies.
Vitamin Fundamentals
Return On Asset | -1.4 | |||
Operating Margin | (0.78) % | |||
Current Valuation | 766.89 K | |||
Shares Outstanding | 783.4 M | |||
Price To Earning | (0.40) X | |||
Price To Sales | 4.82 X | |||
Revenue | 250.03 K | |||
Gross Profit | 55.5 K | |||
EBITDA | (112.37 K) | |||
Net Income | (21.08 K) | |||
Cash And Equivalents | 2.52 K | |||
Total Debt | 307.37 K | |||
Current Ratio | 0.04 X | |||
Book Value Per Share | (0) X | |||
Cash Flow From Operations | 7.69 K | |||
Earnings Per Share | (0) X | |||
Beta | 48.49 | |||
Market Capitalization | 14.1 K | |||
Total Asset | 31.72 K | |||
Retained Earnings | (2.84 M) | |||
Working Capital | (706 K) | |||
Current Asset | 30 K | |||
Current Liabilities | 736 K | |||
Net Asset | 31.72 K |
About Vitamin Blue Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vitamin Blue's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vitamin Blue using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vitamin Blue based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vitamin Blue. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Vitamin Pink Sheet analysis
When running Vitamin Blue's price analysis, check to measure Vitamin Blue's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vitamin Blue is operating at the current time. Most of Vitamin Blue's value examination focuses on studying past and present price action to predict the probability of Vitamin Blue's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vitamin Blue's price. Additionally, you may evaluate how the addition of Vitamin Blue to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |